Latanoprost Rivopharm (Latanoprost)

Latanoprost activates prostaglandin F (FP) receptors in the eye, promoting remodeling of the extracellular matrix and increasing uveoscleral outflow of aqueous humor, which lowers intra‑ocular pressure.

The prescribed dose is determined by the treating ophthalmologist. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but exact dosing must follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the prescriber should evaluate each case individually.

Enquiries can be submitted on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally provides greater IOP reduction with once‑daily dosing compared with beta‑blockers or carbonic anhydrase inhibitors. It is often preferred as first‑line therapy for its efficacy and convenient dosing schedule.

Store at room temperature: keep the bottle in its original packaging, protect it from light and moisture, and avoid freezing. Do not refrigerate the product.

Latanoprost Rivopharm is supplied as sterile eye‑drop solution. The patient should wash hands, tilt the head back, pull down the lower eyelid, and instill one drop into the prescribed eye(s) as directed by the ophthalmologist.

Serious risks include severe allergic reactions, uveitis, corneal edema, and a sudden increase in intra‑ocular pressure. Patients should seek immediate medical attention if they experience intense eye pain, vision loss, or signs of infection.

Patients with known hypersensitivity to latanoprost or any component of the formulation, active ocular infections, or a history of herpetic eye disease should avoid using this medication unless directed otherwise by their eye‑care professional.